Silo Pharma, Inc. to acquire Norsight Consulting Inc.

Silo Pharma, Inc. has agreed to acquire assets from Norsight Consulting Inc. in a transaction announced on 2 October 2026. Both companies are based in the United States and operate within the healthcare sector. The deal structure involves the transfer of specific assets rather than the purchase of equity, with Silo Pharma providing shares as the sole form of consideration. The financial value of the transaction has not been disclosed, and no specific currency or monetary figure has been reported. This asset sale represents a strategic move for Silo Pharma to integrate selected operational elements of Norsight Consulting into its existing portfolio. The arrangement highlights a focus on targeted asset acquisition within the US healthcare market, allowing the buyer to select specific components of the target business. As both entities are domestic to the US, the transaction does not involve cross-border regulatory complexities typically associated with international mergers. The primary consideration is equity-based, aligning the interests of the parties through shared ownership of the acquiring entity.

The transaction is currently at the firm intention stage, with no completion date reported.